Cover image for The coming cancer breakthroughs: #b what you need to know about the latest cancer treatment options
Title:
The coming cancer breakthroughs: #b what you need to know about the latest cancer treatment options
Author:
Dooley, Joseph F.
Personal Author:
Publication Information:
New York : Kensington Books; Southampton : Mallard, [2002]

©2002
Physical Description:
xx, 252 pages ; 22 cm
General Note:
Includes index.
Language:
English
Added Author:
ISBN:
9781575668437
Format :
Book

Available:*

Library
Call Number
Material Type
Home Location
Status
Item Holds
Searching...
RC270.8 .D66 2002 Adult Non-Fiction Central Closed Stacks
Searching...

On Order

Summary

Summary

A leading biochemist and a cancer survivor offer a cutting-edge, up-to-the-minute, empowering guide that arms readers with the knowledge to take the offensive against cancer--and win.


Reviews 1

Library Journal Review

Dooley's expertise as a clinical biochemist coupled with Betancort's proficiency as a health writer and experience as a cancer survivor make for an informative, well-researched resource on cutting-edge treatments for many cancers, including breast, ovarian, prostate, lung, and digestive-tract cancers, as well as leukemias and melanoma. Among the innovative therapies discussed are vaccines, immunotherapy, interferons, gene therapy, and monoclonal antibodies. Dooley and Bentacourt explain complex concepts, such as cell mutations that cause cancer, in terms most lay readers can understand. Especially useful are the chapters on biotechnology, clinical trials, and diagnostic testing. The appendixes include a list of National Cancer Institute-designated cancer centers, cancer information resources, and biotech research centers. Recommended for larger public library health collections that lack a current work on cancer treatment and all consumer health libraries that include cancer resources. Valeria Long, Grand Valley State Univ. Lib. at the Van Andel Inst., Grand Rapids, MI (c) Copyright 2010. Library Journals LLC, a wholly owned subsidiary of Media Source, Inc. No redistribution permitted.